Skip to main content

Swayze Eric's Form 4 filing

Ionis Pharmaceuticals Inc (IONS) · filed Feb 2, 2024

Accession no.
0000874015-24-000110
Filed
Feb 2, 2024
Trade date
Jan 31-Feb 2, 2024
Filing delay
2 days
Rule 10b5-1 plan
Checked

This filing lists 3 non-derivative transactions. Open-market sales total $654.7K. It was filed 2 days after the trade.

This filing was later replaced by the amendment 0000874015-24-000196 (Sep 4, 2024). Trade tables on this site use the amended version.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Swayze EricCIK 0001791058Officer (EVP Research)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Jan 31, 2024Common StockSSaleDisposed−10,773$52.00−$560,19632,516Direct
Feb 1, 2024Common StockAGrant or awardAcquired+3,715$0.00$036,231Direct
Feb 2, 2024Common StockSSaleDisposed−1,907$49.56F3−$94,510.9234,324Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F3

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $49.55 to $49.57 inclusive. The reporting person undertakes to provide to Ionis Pharmaceuticals, Inc. any security holder of Ionis Pharmaceuticals, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (3) on this Form 4.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)